Latest News and Articles
DMD mice sustain dystrophin expression one year after AAV-CRISPR therapy
Cell Therapy Quality/CMC & Analytics – Full Spotlight
Cell therapy startup Mogrify raises 3.7 million USD in seed funding
Managing Starting Material Stability to Maximize Manufacturing Flexibility & Downstream Efficiency
CELL & GENE THERAPY INSIGHTS
Senior Editor: Prof. Chris Mason, AVROBIO and UCL, UK
The peer-reviewed, open access publication bringing you the latest research, reviews and updates from across the sector
BioInsights – the publisher of Cell & Gene Therapy Insights
– is your content marketing partner for life sciences.
Sponsorship
